<!DOCTYPE html>
<html manifest="manifest.manifest">
<head>
	<meta http-equiv=Content-Type content="text/html; charset=utf-8">
	<title>MRCG Clinical Guidelines</title>
	<meta name="viewport" content="width=device-width, initial-scale=1.0, minimum-scale=1.0, maximum-scale=2.0, user-scalable=1">
  
	<meta name=Generator content="Microsoft Word 14 (filtered)">
	<link rel="manifest" href="/manifest.json">	
<link rel="stylesheet" href="jquery.mobile-1.4.5.min.css" />
	<link rel="stylesheet" href="mystyle.css" />
	<script src="jquery-1.11.1.min.js"></script>
	<script src="jquery.mobile-1.4.5.min.js"></script>
	<script type="text/javascript" src="cordova.js"></script>
	<script>
	    		$(function(){
			$("[data-role='header'], [data-role='footer']").toolbar();
		});
  	  $(document).one('pagebeforecreate', function () {
	        $('input[data-type="search"]').val("");
	    	        $.get("panel.html", function (data2) {
            $.mobile.pageContainer.prepend(data2);
              $("[data-role=panel]").panel().enhanceWithin();
        }, "html");
	           $.get("header.html", function (data) {
      $.mobile.pageContainer.prepend(data);
      $("[data-role='header']").toolbar().enhanceWithin();
    }, "html");
    $.get("footer.html", function (data) {
      $.mobile.pageContainer.append(data);
      $("[data-role='footer']").toolbar().enhanceWithin();
    }, "html");
        $('.WordSection1').wrap('<div role="main" class="ui-content">');
        $('table').wrap('<div class="tableCont"></div>');
        $('img').wrap('<div class="tableCont"></div>');
        $.mobile.pageContainer.enhanceWithin();
	  });
	        $(document).bind( "pagechange", function( ) {
        $('table').wrap('<div class="tableCont"></div>');
        $('img').wrap('<div class="tableCont"></div>');
        $('.tableCont').enhanceWithin();
      } );
			// When the user scrolls down 20px from the top of the document, show the button
		window.onscroll = function() {scrollFunction()};
		function scrollFunction() {
		  if (document.body.scrollTop > 20 || document.documentElement.scrollTop > 20) {
			document.getElementById("myBtn").style.display = "block";
		  } else {
			document.getElementById("myBtn").style.display = "none";
		  }
		}
		// When the user clicks on the button, scroll to the top of the document
		function topFunction() {
		  document.body.scrollTop = 0; // For Safari
		  document.documentElement.scrollTop = 0; // For Chrome, Firefox, IE and Opera
		}</script>      
	





	






  
  
  	
</head>
<body lang=EN-GB link=blue vlink=purple>
	
<div data-role="page">
	<div role="main" class="ui-content">
<div class=WordSection1>
<h1>Palliative care</h1>
<h2><i><span lang=EN-US>Executive summary</span></i></h2>
<h2><span lang=EN-US>Introduction</span></h2>
<h2><span style='font-size:11.0pt;font-weight:normal'>Palliative care is given
when a patient is known to be dying or when they have a condition which cannot
be cured and which will cause them to gradually deteriorate until they die. The
priority under these circumstances is to maintain the patient’s comfort and to
avoid distressing interventions or, indeed, any intervention that is
uncomfortable unless there is a clear benefit. </span></h2>
<h2><span lang=EN-US>Target users</span></h2>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Nurses</span></p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span lang=EN-US
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Doctors</span></p>
<h2><span lang=EN-US>Target area of use </span></h2>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Outpatient department</span></p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span lang=EN-US
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Ward</span></p>
<h2><span lang=EN-US>Key areas of focus / New additions / Changes </span></h2>
<p class=MsoNormal><span lang=EN-US>This guideline briefly discusses the
principles of palliative care and the important decisions that need to be made.
It outlines the treatment options available to patients receiving palliative
care.</span></p>
<h2><span lang=EN-US>Limitations</span></h2>
<p class=MsoNormal><span lang=EN-US>None</span></p>
<span style='font-size:11.0pt;font-family:"Arial","sans-serif"'><br clear=all
style='page-break-before:always'>
</span>
<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
style='font-size:12.0pt'>&nbsp;</span></b></p>
<h2>Decisions about resuscitation and escalation of treatment</h2>
<p class=MsoNormal>The doctors should make a decision to approach a patient
palliatively when they have a diagnosis that is causing significant symptoms
and which cannot be reversed. This can be a very difficult call to make and
where there is uncertainty, it is appropriate to involve a consultant in the
decision-making process. </p>
<p class=MsoNormal>Once the decision has been made that a patient should be
approached palliatively, two other factors should be considered. </p>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Is this patient likely to die during this admission? Should they
be resuscitated if they die? </p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Should the nurses continue to check their observations? Even if
they continue, should they calculate MEWS and alert the doctors about any
changes?</p>
<p class=MsoNormal>Both of these topics must be discussed with a consultant and
any decision not to attempt resuscitation or not to calculate MEWS should be
clearly documented in the notes and communicated to all staff looking after the
patient. </p>
<p class=MsoNormal>There must be careful consideration of how this is
communicated with the patient and their relatives. International best practice
suggests that this communication occurs, but this must be modified in
accordance with our cultural context. The senior staff of the department should
be consulted about this. </p>
<h2>Approach to the patient receiving palliative care</h2>
<h3>Important issues to consider</h3>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Does the patient need to be kept in hospital or can their needs
be met at home? If they can go home, do the carers know how to look after the
patient? Do they know what to do if they need help or they have any questions
or concerns?</p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Does the patient need all the medications they are currently
taking? Are the medicines likely to improve the outcome or the symptoms that
the patient has? Are they causing any side effects?</p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Is the patient in pain? If they are taking strong pain killers,
are they nauseated and have they been to toilet? Do they have any other side
effects?</p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Are there any other distressing symptoms – cough, shortness of
breath, difficulty sleeping etc?</p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Can the patient swallow? What are they eating or drinking?</p>
<h2>Specific treatments</h2>
<p class=MsoNormal>In a palliative care setting, it is sometimes appropriate to
use medications in unusual ways. This is because the risk of addiction is not
important and because the patient’s comfort is more important than theoretical
long term risks. Many of the recommendations below are, therefore, unlicensed
and should only be prescribed by a doctor.</p>
<h3>Pain</h3>
<p class=MsoNormal>Pain relief in palliative care is aimed at controlling the pain
completely. It is better to give medications regularly and in adequate doses to
prevent pain than to give pain relief once the pain has developed. Different
medications can be used in combination to effectively treat the patient. </p>
<p class=MsoNormal>It is best to begin with simple analgesia and gradually
increase the strength of medications given until the pain is controlled.
However, in our setting, patients often present in severe established pain and,
in these circumstances, we must be more aggressive in our treatment. </p>
<p class=MsoNormal>Note that all patients prescribed codeine or morphine in a
palliative care setting must also be prescribed medication for nausea and
constipation.</p>
<p class=MsoNormal><u>Simple pain relief</u></p>
<p class=MsoNormal>Paracetamol should be used in the first instance at a dose
of 15 mg/kg up to 1 g PO QDS. This should be spread throughout the 24 hour
period. </p>
<p class=MsoNormal>If this is not adequate, consider introducing ibuprofen 10
mg/kg up to 400 mg PO TDS. This is contraindicated in patients with a history
of dyspepsia and must be taken after food. Ibuprofen is an anti-inflammatory
agent, so is particularly effective where inflammation is causing the pain and
is the first line option in these circumstances. </p>
<p class=MsoNormal><u>Mild opiates</u></p>
<p class=MsoNormal>If simple analgesia is not effective, then add codeine. </p>
<p class=MsoNormal>Codeine phosphate is useful for moderate pain. Give 1 mg/kg
up to 60 mg PO TDS.</p>
<p class=MsoNormal>Some doctors like to use tramadol at this point. However,
this is a partial agonist with complex pharmacokinetics. This means it cannot
be used in combination with strong opiates and that it is impossible to predict
what dose will be needed in any particular patient. </p>
<p class=MsoNormal><u>Strong opiates</u></p>
<p class=MsoNormal>These should be introduced in the place of mild opiates if
they have not been effective in controlling the pain or if the patient is in
severe pain, they may be used in the first instance.</p>
<p class=MsoNormal>All patients should be prescribed both a regular dose of
morphine (usually as MST) as well as a PRN dose of oral morphine solution to be
given if they experience breakthrough pain. The dose of the PRN dose is usually
one third of that of the regular BD MST dose. </p>
<p class=MsoNormal>The initial dose of morphine is 0.1 mg/kg up to 5 mg PO
every 4 hours for oral morphine solution or 0.3 mg/kg up to 15 mg PO BD for
MST. If the patient is already taking codeine, then divide the total daily dose
by 8-10 to get the equivalent total daily dose of morphine. (A patient taking
60 mg TDS of codeine needs at least 18-22 mg a day of morphine for the
equivalent effect).</p>
<p class=MsoNormal>Note that MST must be given strictly every 12 hours and
should never be given more frequently than this. The dose must be increased
instead of the frequency. The dose should be increased under the supervision of
the doctors until the patient’s pain is controlled.</p>
<p class=MsoNormal><u>Specific kinds of pain:</u></p>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Neuropathic pain – shooting or burning pains which do not respond
to simple pain relief or to opiates. Amitriptyline 0.2 mg/kg up to 50 mg PO
should be given at night. </p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Muscle spasm – give diazepam 0.25 mg/kg up to 5 mg PO TDS (note
that this should only ever be given to palliative care patients for this
indication).</p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Colicky pain – pain due to gastric or intestinal spasm may be
improved by Buscopan <span lang=EN-US style='color:black;background:white'>(hyoscine
butylbromide)</span><span lang=EN-US style='color:black'> </span>0.3 mg/kg up
to 10 mg TDS – this is not on our formulary, but is easily obtained from local
pharmacies. Loperamide 0.1 mg/kg up to 4 mg PO QDS is an alternative, but will
cause constipation.</p>
<h3>Poor appetite</h3>
<p class=MsoNormal>Consider using prednisolone 0.5-1 mg/kg up to 15-30 mg PO
OD.</p>
<h3>Dry or sore mouth</h3>
<p class=MsoNormal>Examine the mouth for candida and treat with nystatin oral
solution 1,000,000 units QDS if found. </p>
<p class=MsoNormal>If there is no obvious cause, sucking papaya or pineapple
slices can be very effective.</p>
<p class=MsoNormal>If the mouth is very sore, a loperamide capsule can be
opened and the contents suspended in water. The suspension should be swilled
around the mouth and spat out. This can be done up to 4 times a day and
provides very effective local pain relief. </p>
<h3>Difficulty swallowing</h3>
<p class=MsoNormal>If there is an obstructing tumour, try dexamethasone 0.15
mg/kg up to 8 mg OD to temporarily reduce the obstruction. If this is not
available, the equivalent dose of prednisolone is 1-2 mg/kg up to 50 mg OD. </p>
<p class=MsoNormal>Check that there is no evidence of oesophageal candidiasis.
If there is, then treat with fluconazole 3 mg/kg up to 200 mg OD. </p>
<h3>Hiccups</h3>
<p class=MsoNormal>This is often a consequence of gastric distension and can be
treated with magnesium trisilicate. If this doesn’t help, try omeprazole 0.5
mg/kg up to 20 mg OD and metoclopramide 0.1 mg/kg up to 10 mg TDS. Other
alternatives include chlorpromazine 0.5 mg/kg up to 25 mg up to TDS and
nifedipine 0.5 mg/kg up to 20 mg OD. </p>
<h3>Nausea and vomiting</h3>
<p class=MsoNormal>The cause of this must be identified and treated. The
commonest cause is related to opiate prescription and all patients receiving
opiates should be prescribed anti-emetics prophylactically. Often the nausea
settles after 4-5 days of treatment and the anti-emetic can then be stopped.
Haloperidol, metoclopramide and promethazine are all effective. </p>
<p class=MsoNormal>Metoclopramide 0.1 mg/kg up to 10 mg PO TDS is useful for
gastric and functional intestinal causes of nausea and vomiting. </p>
<p class=MsoNormal>Promethazine 0.5 mg/kg up to 25 mg PO TDS can be used when
the cause is mechanical obstruction or raised intracranial pressure. </p>
<p class=MsoNormal>Haloperidol 0.125 mg/kg up to 1.5 mg PO up to BD is
particularly useful when the cause is renal failure or suspected electrolyte
disturbance. </p>
<h3>Constipation</h3>
<p class=MsoNormal>This is often distressing for patients and is an inevitable
consequence of treatment with opiates. Lactulose 2.5-20ml PO BD should be given
to prevent this. Once constipation develops, patients often need bisacodyl 5-20
mg PO at night.</p>
<span style='font-size:11.0pt;font-family:"Arial","sans-serif"'><br clear=all
style='page-break-before:always'>
</span>
<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><u><span
 style='text-decoration:none'>&nbsp;</span></u></b></p>
<h3>Fitting</h3>
<p class=MsoNormal>This is common in patients with cerebral tumours, but is
also seen in patients with uraemia. Phenytoin (starting dose 1.5-2.5 mg/kg up
to 150 mg BD) or carbamazepine (starting dose 5 mg/kg up to 200 mg at night)
should be prescribed early – even before a fit has occurred if the patient is
at risk of this.</p>
<h3>Restlessness and confusion</h3>
<p class=MsoNormal>This may require treatment with an antipsychotic. The dose
and frequency needs to be adjusted according to the patient’s response. Begin
with promethazine 0.25 mg/kg up to 12.5 mg PO TDS. This can be increased to a
maximum dose of 0.5 mg/kg up to 25 mg TDS. </p>
<p class=MsoNormal>Alternatively, haloperidol may be used at a dose of 0.1-0.25
mg/kg up to 1-3 mg PO up to TDS.</p>
<h3>Raised intracranial pressure</h3>
<p class=MsoNormal>Headache due to raised intracranial pressure should be
treated with high dose steroids. Use dexamethasone 0.3 mg/kg up to 16 mg PO in
the morning for 4-5 days, then reduce to 0.1 mg/kg up to 5 mg OD. </p>
<h3>Difficulty sleeping</h3>
<p class=MsoNormal>Look for the cause of this – possibilities include
discomfort, cramps, night sweats, joint stiffness and fear. The cause should be
treated in the first instance. If this is not effective, diazepam 0.25 mg/kg up
to 5 mg PO at night can be used. </p>
<h3>Shortness of breath</h3>
<p class=MsoNormal>This can be very distressing for patients. If there is any
wheeze or obstruction, try dexamethasone 0.075-0.15 mg/kg up to 4-8 mg PO OD.
If the patient is anxious, diazepam up to 5 mg PO TDS may help. Otherwise, this
symptom often responds to a regular low dose of oral morphine – prescribe as
for pain.</p>
<h3>Intractable cough</h3>
<p class=MsoNormal>Oral morphine is effective if given regularly – usually
lower doses are needed compared to those required for pain relief. </p>
<h3>Fungating tumours and painful wounds</h3>
<p class=MsoNormal>Fungating smelly tumours should be dressed and treated with
topical metronidazole, which is made up by crushing metronidazole tablets into
paraffin ointment. Some patients will require oral metronidazole. </p>
<p class=MsoNormal>Where wounds are painful, this can be reduced by opening a
loperamide capsule and suspending the contents in water. The suspension can be
painted over the wound as often as necessary. </p>
<h3>Itch</h3>
<p class=MsoNormal>This is often helped by the use of emulsifying ointment –
which can be rubbed on as often is necessary. Anti-histamines are usually
ineffective and may cause significant side effects. </p>
<span style='font-size:11.0pt;font-family:"Arial","sans-serif"'><br clear=all
style='page-break-before:always'>
</span>
<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
style='font-size:12.0pt'>&nbsp;</span></b></p>
<h2>Key Issues for Nursing care</h2>
<h2><span style='font-size:11.0pt;font-weight:normal'>It is very important that
patients know that they can ask for help at any time. Tell them and their
relatives to inform the nursing staff if they are in pain, vomiting or having
any other symptoms. If a patient informs you about these problems, check the drug
chart and dispense any PRN medications prescribed. If the problems are new or
nothing is prescribed, call the doctor to review the patient. </span></h2>
<p class=MsoNormal>Patients and their relatives may be very afraid during this
phase of care. Take time to listen to them, to identify their fears and to
honestly reassure them. This does not mean telling them not to worry, but
reassuring them that we are there to help and will do all we can to ensure they
are not in any discomfort or distress.</p>
<p class=MsoNormal>Ensure you are aware of which patients are for palliative
care. Check if MEWS should be calculated and if resuscitation is to be
initiated if they deteriorate. </p>
<h2>References</h2>
<p class=MsoNormal><span lang=EN-US style='font-size:8.0pt'>Joint Formulary
Committee (2016) British National Formulary. 72nd Ed., London: British Medical
Association and &nbsp;Royal Pharmaceutical Society of Great Britain.</span></p>
<p class=MsoNormal><span lang=EN-US style='font-size:8.0pt'>Joint Formulary
Committee (2016) British National Formulary for Children. London: British
Medical Association and &nbsp;Royal Pharmaceutical Society of Great Britain.</span></p>
<div class="tableCont">
  <table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b>Written
  by:</b></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'>Name: Karen
  Forrest</p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'>Date: 06
  November 2018</p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b>Reviewed
  by:</b></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'>Name: Fatai
  Akemokwe</p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'>Date: 14
  November 2018</p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b>Version:</b></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b>Change
  history:</b></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b>Review
  due date:</b></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'>1.0</p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'>New
  document</p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'>31 January
  2021</p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'>1.1</p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'>Executive
  summary added</p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'>31 January
  2021</p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'>Review
  Comments (<i>if applicable)</i></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'>&nbsp;</p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b>&nbsp;</b></p>
  </td>
 </tr>
</table>
</div>
<p class=MsoNormal>&nbsp;</p>
<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>
</div>
</div><!-- /content -->

</div>

</body>
</html>
